DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 51 · January 2013 DOI: 10.1055/s-003-24333


29. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Hannover, 25.–26. 1. 2013

Kongresspräsident: Prof. Dr. Michael P. Manns

V_1_01
Hammerich, L; Heymann, F; Zimmermann, HW; Bangen, JM; Gaßler, N; Huss, S; Liedtke, C; Prinz, I; Lira, SA; Luedde, T; Trautwein, C; Tacke, F: Hepatic accumulation of IL-17 producing γδ T cells via chemokine receptor CCR6 restricts liver inflammation and fibrosis by inhibiting hepatic stellate cells
V_1_02
Wuestefeld, T; Pesic, M; Longerich, T; Kang, TW; Yevsa, T; Dauch, D; Potapova, A; Rudalska, R; Rittelmeyer, I; Jarek, M; Geffers, R; Scharfe, M; Klawonn, F; Malek, NP; Schirmacher, P; Ott, M; Vogel, A; Manns, MP; Zender, L: In vivo RNAi screening identified MKK4 as a new therapeutic target for the improvement of liver regeneration
V_1_03
Jeliazkova, P; Jörs, S; Lee, M; Zimber-Strobl, U; Ferrer, J; Schmid, RM; Siveke, JT; Geisler, F: Notch2 converts hepatoblasts and adult hepatocytes to the biliary lineage via canonical Notch signalling independent of Hes1 in mice
P_1_01
Al-samman, M; Meurer, SK; Sahin, H; Wasmuth, HE; Kisseleva, T; Brenner, D; Trautwein, C; Weiskirchen, R; Scholten, D: Effekt von Endoglin auf die Differenzierung und das Signalling in einer neuen Col-GFP-exprimierenden immortalisierten murinen Sternzell-Linie
P_1_02
Bangen, JM; Hammerich, L; Lambertz, D; Huss, S; Barbacid, M; Trautwein, C; Liedtke, C: Genetische Inaktivierung von CdK2 in Hepatozyten führt zu erhöhter Fibrogenese in der Leber
P_1_03
P_1_04
Borkham-Kamphorst, E; van de Leur, E; Zimmermann, HW; Karlmark, KR; Tihaa, L; Haas, U; Tacke, F; Berger, T; Mak, TW; Weiskirchen, R: Protective effects of Lipocalin-2 (LCN2) in acute and chronic liver injury indicate a novel function in liver homeostasis
P_1_05
Böttger, J; Zellmer, S; Scheller, J; Ueberham, E; Rose-John, S; Gebhardt, R: Hyper-Interleukin-6 dependent changes in normal and regenerating mouse livers
P_1_06
Böttger, J; Ueberham, E; Zellmer, S; Scheller, J; Rose-John, S; Gebhardt, R: Untersuchungen zum Einfluss von Glial-fibrilaric-acidic-protein (GFAP) am Umbau der Mausleber
P_1_08
Cubero, FJ; Zhao, G; Hatting, M; Nevzorova, YA; Boekschoten, MV; Drvarov, O; Roskams, T; Müller, M; Davis, RJ; Trautwein, C: Hepatic Stellate Cells-derived JNK1 is a crucial mediator
P_1_09
Cubero, FJ; Zhao, G; Nevzorova, YA; Hatting, M; Hermanns, N; Schäfer, F; Drvarov, O; Gaßler, N; Liedtke, C; Trautwein, C: Crosstalk between IKKγ/Nemo and the Jnk genes in the progression from hepatitis to hepatocellular carcinoma
P_1_10
Czech, B; Valletta, D; Saugspier, M; Müller, M; Bosserhoff, A; Hellerbrand, C: Effect of increased glucose transporter 1 (GLUT1) expression in activated hepatic stellate cells
P_1_11
Czech, B; Valletta, D; Dettmer, K; Müller, M; Bosserhoff, A; Oefner, P; Hellerbrand, C: Functional effects of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease
P_1_12
Czech, B; Weigand, K; Neumann, I; Müller, M; Reber, S; Hellerbrand, C: Combination of psychosocial stress and a NASH-inducing diet in mice
P_1_13
P_1_14
Dorn, C; Engelmann, J; Saugspier, M; Hartmann, A; Müller, M; Spang, R; Bosserhoff, A; Hellerbrand, C: Increased expression of c-jun in nonalcoholic fatty liver disease
P_1_15
Galante, A; Jagemann, B; Lohse, AW; Lüth, S: No evidence for increased intestinal permeability in cirrhosis
P_1_16
Genz, B; Reetz, J; Meier, C; Kowtharapu, BS; Stoll, A; Timm, F; Vollmar, B; Pützer, B; Abshagen, K; Herchenröder, O: Adenoviral-mediated specific targeting of hepatic stellate cells as a selective therapeutic approach in liver fibrosis
P_1_17
Glässner, A; Kokordelis, P; Eisenhardt, M; Krämer, B; Wolter, F; Nischalke, HD; Boesecke, C; Strassburg, CP; Rockstroh, JK; Spengler, U; Nattermann, J: NK-Zellen aus HIV/HCV koinfizierten Patienten besitzen im Vergleich zu HCV monoinfizierten Patienten eine verminderte anti-fibrotische Aktivität
P_1_18
Granzow, M; Klein, S; Schierwagen, R; Heinzen, J; Huss, S; Sauerbruch, T; Trebicka, J: beta-Arrestin-2 ist an der hepatischen Fibrogenese beteiligt
P_1_19
P_1_20
Heinrichs, D; Berres, ML; Nellen, A; Fischer, P; Trautwein, C; Wasmuth, HE; Sahin, H: Macrophage inflammatory protein-1α shows profibrotic effects in two experimental liver fibosis
P_1_21
Hintermann, E; Ehser, J; Bayer, M; Pfeilschifter, J; Christen, U: Induction of hepatic fibrosis by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6
P_1_22
Hochrath, K; Goebel, R; Hiththetiya, K; Stokes, C; Lammert, F: Vitamin D modulates biliary fibrosis in ABCB4 deficient mice
P_1_23
P_1_24
Kegel, V; Schulz, T; Burkhardt, B; Haase, A; Zellmer, S; Luch, A; Seehofer, D; Glanemann, M; Nüssler, A; Damm, G: Establishment of a human in vitro model to investigate inflammatory immune reactions between Kupffer cell activation and hepatocyte damage – an approach to study DILI
P_1_25
Kirstein, MM; Puls, F; Krech, T; Schlue, J; Dämmrich, ME; Pischke, S; Kreipe, HH; Manns, MP; Vogel, A: The clinical presentation and prognosis of patients with Congenital Hepatic Fibrosis
P_1_26
Klein, S; Grace, J; Granzow, M; Schierwagen, R; Masing, N; Herath, C; Burell, L; Angus, P; Sauerbruch, T; Trebicka, J: Intramural gebildetes Angiotensin 1–7 bewirkt eine splanchnische Vasodilatation via Mas-Rezeptor Stimulierung und induziert dadurch eine vaskuläre Dysfunktion in der Leberzirrhose
P_1_31
Mahli, A; Saugspier, M; Thasler, WE; Müller, M; Hellerbrand, C: In vitro and in vivo models for irinotecan induced steatohepatitis
P_1_33
Mogler, C; Wieland, M; Hu, J; Sivanandam, V; Korn, C; Arnsperger, T; Neumann, A; Longerich, T; Schirmacher, P; Augustin, HG: Control of hepatic stellate cells of liver health and disease
P_1_34
Moriconi, F; Malik, IA; Amanzada, A; Ramadori, G; Hess, CF: Rat model of long term effects after fractionated (2Gy/day) 60Gy irradiation of rat liver
P_1_36
Nischalke, HD; Berger, C; Luda, C; Wolter, F; Krämer, B; Glässner, A; Eisenhardt, M; Nattermann, J; Sauerbruch, T; Strassburg, CP; Spengler, U: Der rs4240624 Polymorphismus im PPP1R3B Gen zeigt keinen Einfluss bei alkoholischer Zirrhose und hepatozellulärem Karzinom
P_1_40
Pinna, F; Sahle, S; Beuke, K; Bissinger, MB; Tuncay, S; D'Alessandro, L; Gauges, R; Timmer, J; Raue, A; Klingmüller, U; Schirmacher, P; Kummer, U; Breuhahn, K: Role of protein turnover in NF-κB signalling: A systems biology study on primary hepatocytes
P_1_41
Reinhard, H; Roderfeld, M; Pasupuleti, S; Tschuschner, A; Kopsch, K; Kremer, S; Churin, Y; Roeb, E: Etablierung und Charakterisierung eines murinen second Hit- Modells für die virale medikamentös- toxische Leberschädigung
P_1_42
P_1_43
Roderfeld, M; Hage, L; Rath, T; Tschuschner, A; Nährlich, L; Schulz, R; Zachoval, R; Roeb, E: TIMP-4 und Endoglin sowie die Transiente Elastografie sind für die nicht invasive Diagnostik der Leberbeteiligung bei Zystischer Fibrose geeignet
P_1_45
Saugspier, M; Dorn, C; Engelmann, J; Weiss, TS; Müller, M; Spang, R; Hellerbrand, C: Aging promotes progression of non-alcoholic fatty liver disease in mice
P_1_46
Schaffrath, C; Borkham-Kamphorst, E; van de Leur, E; Tihaa, L; Haas, U; Weiskirchen, R: Expression analysis of CCN1/CYR61 in primary liver cells and in models of experimental liver fibrogenesis
P_1_47
Schierwagen, R; Granzow, M; Klein, S; Kowallick, B; Vogt, A; Gonzalez-Carmona, M; Huss, S; Sauerbruch, T; Trebicka, J: AT1-Rezeptor vermittelte Aktivierung der Janus-Kinase 2 (JAK2) in myofibroblastischen aktivierten hepatischen Sternzellen wirkt fibrogenetisch und erhöht den Portaldruck
P_1_48
Schlosser, M; Wojtalla, A; Schildberg, FA; Knolle, PA; Singer, MV; Sauerbruch, T; Zimmer, A; Siegmund, SV: The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells
P_1_56
Weng, HL; Liu, Y; Shen, Z; Xu, MY; Liebe, R; Zimmer, V; Lammert, F; ten Dijke, P; Lu, LG; Li, Y; Dooley, S: Notch signaling participates in liver fibrosis
P_1_57
Wertenbruch, S; Großarth, V; Kaldenbach, M; Bennek, E; Heinrich, D; Zhao, G; Sellge, G; Trautwein, C; Brandenburg, LO; Streetz, KL: Die Rolle des Antimikrobiellen Peptides LL-37/CRAMP in der Leberfibrose